(Q42980751)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

title

A randomized trial of consensus interferon in combination with ribavirin as initial treatment for chronic hepatitis C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Stefano Milani

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

author name string

Giovanna Fattovich

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Irene Zagni

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Eliseo Minola

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Martina Felder

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Pierangelo Rovere

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Antonio Carlotto

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Sergio Suppressa

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Anna Miracolo

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Claudio Paternoster

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Caterina Rizzo

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Angelo Rossini

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Paolo Benedetti

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Marco Capanni

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Chiara Ferrara

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Paolo Costa

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Tosca Bertin

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Maurizio Pantalena

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Lorenzo Lomonaco

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Chiara Scattolini

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Massimo Giusti

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Sergio Boccia

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Renato Marin

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Maria Lisa Ribero

25

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

Alessandro Tagger

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

publication date

1 November 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

published in

Journal of Hepatology

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

volume

39

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

page(s)

843-849

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon

20 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900391-X

7 January 2021

Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900391-X

7 January 2021

Therapy of hepatitis C: consensus interferon trials. Consensus Interferon Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900391-X

7 January 2021

Treatment of chronic hepatitis C virus infection with recombinant consensus interferon

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900391-X

7 January 2021

Re-treatment of chronic hepatitis C with consensus interferon .

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900391-X

7 January 2021

Biochemical and viral response to consensus interferon (CIFN) therapy in chronic hepatitis C patients: effect of baseline viral concentration. Consensus Interferon Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900391-X

7 January 2021

National Institutes of Health Consensus Development Conference Panel statement: management of hepatitis C

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900391-X

7 January 2021

Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900391-X

7 January 2021

Randomised trial of interferon alpha2b plus ribavirin for 48 weeks or for 24 weeks versus interferon alpha2b plus placebo for 48 weeks for treatment of chronic infection with hepatitis C virus. International Hepatitis Interventional Therapy Group (I

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900391-X

7 January 2021

Efficacy of prolonged 5 million units of interferon in combination with ribavirin for relapser patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900391-X

7 January 2021

Classification of chronic viral hepatitis: a need for reassessment

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900391-X

7 January 2021

Adherence to protease inhibitor therapy and outcomes in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900391-X

7 January 2021

Adherence to combination therapy enhances sustained response in genotype-1-infected patients with chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900391-X

7 January 2021

Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900391-X

7 January 2021

Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0168-8278%2803%2900391-X

7 January 2021

10.1016/S0168-8278(03)00391-X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14568269%20AND%20SRC:MED&resulttype=core&format=json

20 December 2019

1 reference